摘要
糖尿病心肌病的发病机制目前尚不清楚,本文总结近年来的研究成果,从发病机理、 诊断及治疗三方面作一综述。
参考文献18
-
1Braunwald. Heart Disease: A Textbook of Cardiovascular Medicine. 6thed. 2001 :2133～2150
-
2Choi KM,ZhongY, Hoit BD, et al. Am J Physiol Heart Circ Physiol,2002 ;283 (4): H1398-H1408
-
3Rozanski GJ,Xu Z. Clin Exp Pharmacol Physiol,2002;29(1- 2) :132-137
-
4Qin D, Huang B,Deng L, et al. Biochem Biophys Res Commun,2001 ;283(3): 549-553
-
5Norby FL,Wold LE,Duaan J ,et al. Am J Physiol Endocrinol Metab, 2002 ; 283 (4) : E658 - E666
-
6Kajstura J,Fiordaliso F, Andreoli AM,et al. Diabetes,2001 ; 50(6) : 1414- 1424
-
7Way KJ,Isshiki K,Suzuma K,et al. Diabetes,2002;51 (9) :2709-2718
-
8Cai L, Li W,Wang G,et al. Diabetes , 2002 ; 51 (6):1938-1948
-
9Listenberger LL,Schaffer JE. Trends Cardiovasc Med,2002; 12(3) : 134-138
-
10Unger RH,Orci L. FASEB J,2001 ; 15(2) :312-321
同被引文献15
-
1王先银,李树森,廖明松.糖尿病心肌病的研究进展[J].西部医学,2005,17(6):617-619. 被引量：9
-
2Martens P M, Visseren F L, Lemay Y, et al. Metabolic and additional vascular effects of thiazolidinediones [J]. Drug, 2002 : 62 (10) : 1 463-1 480.
-
3Giles T D,Ouyang J,Kerut E K,et al. Changese in protein kinase C in early cardiomyopathy and in gracilis muscle in the BB/W or diabetic rat [J]. Am J Physiol Heart and Circ, 1998,274 (1): H295-H307.
-
4Shiomi T, Tsutsui H, Hayasnidani S, et al. Piogtitazone, a peroxisome proliferator-a ctivated receptorgamma agonist,attenuates left ventri cular remodeling and failure after experimental myocardial infarction[J]. Circulation, 2002,106 : 3 126-3 132.
-
5Hasegawa H, Takano H, Zou Y, et al. Pioglitazone,a peroxisome proliferator-activated receptor gamma activator,ameliorates experimental autoimmune myocarditis bymodularting Th1/Th2 balance [J]. Mol Cell Cardiol, 2005,38: 257-265.
-
6Ogata T, Miyauchi T, Sakai S, et al. Myocardial fibrosis and diastolic dysfunction in deoxvcorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptoralpha activator fenofi brate,partly by suppressing inflam-matory responses associated with the nuclear factor-kappa-B pathway [ J]. J Am Coll Cardiol, 2004,21:1 481-1 488.
-
7Golfman L S,Wilson C R,Sharma S,et al. Activation of PPAR gamma enhances myocardial glucose oxidation and improves contractile function in isolated working hearts of ZDF rats[J]. Am J Physiol Endocrinol Metab, 2005,289(2) : E328-E336.
-
8Choi KM, Zhong Y, Hoit BD, et al. Defective intracellular Ca^2+ signaling contributes to cardiomyopathy in Type 1 diabetic rats. Am J Physiol Heart Cire Physiol, 2002,283 (4) : H1398-H1408.
-
9Rozanski GJ, Xu Z. A metabolic mechanism for cardiac K^+ channel remodelling. Clin Exp Pharmacol Physiol, 2002,29 ( 1-2 ) : 132-137.
-
10Qin D, Huang B,Deng L,et al. Downregulation of K+ channel genes expression in type Ⅰ diabeticcardiomyopathy. Biochem Biophys Res Commun, 2001,283 (3) :549-553.
二级引证文献6
-
1王富军,杨立群,齐会卿,甘可欣,杜亚萍,赵允.吡格列酮对2型糖尿病大鼠心肌组织中MMP-9、TIMP-1及胶原表达的影响[J].河北医科大学学报,2010,31(2):139-142. 被引量：2
-
2王春玲,田林红,张涛,张文博,王收宝,孙洁.黄芪对糖尿病大鼠心肌组织中心肌营养素-1表达的影响[J].北京中医药大学学报,2010,33(5):339-341. 被引量：3
-
3丁来标,孔青,杜雅洁.芪苈强心胶囊联合西药治疗糖尿病心肌病心功能不全22例[J].河北中医,2010,32(9):1390-1392. 被引量：4
-
4张展,赵雯,贺建国,张军.速度向量成像评价胰岛素对糖尿病心肌病大鼠心肌功能的影响[J].中国医学影像技术,2011,27(5):869-872. 被引量：6
-
5李华峰,邓政平,邓丽珠.糖尿病性心肌病36例临床分析[J].吉林医学,2014,35(14):3075-3076. 被引量：1
-
6王鑫焱,常立萍,邓悦.解毒通络方对实验性糖尿病心肌病变大鼠保护作用的初步研究[J].北京中医药大学学报,2017,40(8):669-676. 被引量：4
-
1李竹英,韩文英,郅扶旻.中西医结合治疗支气管哮喘急性发作研究进展[J].中国中医急症,2016,25(3):461-463. 被引量：45
-
2投稿须知[J].安徽医科大学学报,2017,52(7):1098-1098.
-
3H.E.Blum,S.Wieland,F.v.Weizscker,W.-B.Offensperger,S.Offensperger,D.Moradpour,I.Chemin,E.Walter,唐振亚.慢性病毒性肝炎基因治疗策略[J].德国医学,1996,13(3):123-126.
